El-Sayed Manal

February 14, 2018 5:26 pm Published by Leave your thoughts1 Comment% Comments

Manal El-Sayed, MD, is Professor of Pediatrics at Ain Shams University, Cairo, Egypt, where she trained in medicine and subsequently completed her masters and doctorate in Pediatrics. Since 1990 she has worked in pediatric hematology and oncology teams developing a program for the management of liver disease in children and adolescents with hematological disorders, malignancies and recipients of bone marrow transplantation at Ain Shams University, National Cancer Institute and 57357 Children’s Cancer Hospital. She is a founding member of the Egyptian National Committee for Control of Viral Hepatitis (NCCVH) since 2006 charged with planning and implementing the nationwide program for prevention and management of viral hepatitis. Professor El-Sayed contributed to the establishment of 55 nationwide specialised liver centers connected through a database networking system for management of patients with viral hepatitis, where 350,000 HCV-infected patients received therapy with interferon.
Read more.

Tags:

Categorised in:

This post was written by SOTO Admin

Tacke Frank

February 14, 2018 5:19 pm Published by Leave your thoughts1 Comment% Comments

Prof. Dr. Frank Tacke, M.D., Ph.D., Associate Professor for Hepato-Gastroenterology and Executive Senior Physician at the Department of Medicine III of the University Hospital Aachen, Germany, was originally educated at the medical school in Hannover, Germany, and Baylor College of Medicine, Houston, TX. Later, he moved to the University of Texas, M.D. Anderson Cancer Centre in Houston, working on new gene therapy strategies (1998-1999), continuing for a post-doctoral research training (2004-2006) at the Mount Sinai Medical Centre, New York, working on monocyte/macrophage and dendritic cell biology.
Read more.

Tags:

Categorised in:

This post was written by SOTO Admin

Sironi Andrea

April 18, 2017 3:03 pm Published by Leave your thoughts1 Comment% Comments

Andrea Sironi is Professor of Banking and Finance at Bocconi University in Milan, where he has been Rector from 2012 to 2016. Since January 2016, he is Chairman of Borsa Italiana SpA and, since October 2016, a member of the Board of Directors of the London Stock Exchange Group. He is currently a member of the Board of Directors of Cassa Depositi e Prestiti SpA and of Cogentech Scarl.
Read more.

Tags:

Categorised in:

This post was written by SOTO Admin

Wiktor Stefan

December 15, 2016 6:18 am Published by Leave your thoughts1 Comment% Comments

Stefan Wiktor is a public-health physician with more than twenty-five years’ experience in epidemiologic research and the implementation of public-health programs. Dr Wiktor is Professor of Medicine and Public Health at the University of Washington in Seattle, U.S.

From 2012-2016, Dr. Wiktor was the Team Lead of the World Health Organization’s Global Hepatitis Programme in Geneva, Switzerland which provides guidance and technical assistance to countries to promote the implementation of comprehensive viral hepatitis prevention and control programs.
Read more.

Tags:

Categorised in:

This post was written by easl_admin

Wedemeyer Heiner

December 15, 2016 6:16 am Published by Leave your thoughts1 Comment% Comments

Heiner Wedemeyer is a Professor at the Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Germany. He leads a research group on cellular immunology and clinical virology of viral hepatitis. He is involved in the scientific coordination of the German Network of Competence on Viral Hepatitis (Hep-Net), the German Liver Foundation and the German Hepatitis C Registry. In 2008, he was elected as a Scientific Committee member of the European Association for the Study of the Liver (EASL), and was Secretary General of EASL from 2009 to 2011.
Read more.

Tags:

Categorised in:

This post was written by easl_admin

Thursz Mark

December 15, 2016 6:15 am Published by Leave your thoughts1 Comment% Comments

Mark Thursz is Professor of Hepatology at Imperial College where he is head of the Digestive Diseases Division and lead clinician for hepatology at St Mary’s Hospital, London. His clinical interests are in viral hepatitis, alcoholic and fatty liver disease.Prof. Thursz is

Prof. Thursz is chief investigator on two multi-centre trials: The warfarin anticoagulation for liver fibrosis in patients transplanted for hepatitis C (WAFT-C) trial and the steroids or pentoxifylline for alcoholic hepatitis (STOPAH) trial. He is chief investigator on the PROLIFICA programme in West Africa.
Read more.

Tags:

Categorised in:

This post was written by easl_admin

Merkt Benoit

December 15, 2016 6:12 am Published by Leave your thoughts1 Comment% Comments

Benoît Merkt, Dr. iur., Attorney at Law, MJur has been a partner of the Swiss law firm Lenz & Staehelin since 2006. He is co-head of Lenz & Staehelin competition law and non-profit/philanthropy practices. He holds a Doctorate in law from the University of Neuchâtel and a Master in European and Comparative Law (MJur) from Oxford University. Benoît Merkt is recognized as a leading competition law expert and a leading practitioner in the law of tax-exempt/non-profit organizations.
Read more.

Tags:

Categorised in:

This post was written by easl_admin

Lazarus Jeffrey

December 15, 2016 6:10 am Published by Leave your thoughts1 Comment% Comments

Jeffrey V. Lazarus holds a  position as an affiliated professor at the WHO Collaborating Centre on HIV and Viral Hepatitis at Rigshospitalet, the University of Copenhagen and as an associated researcher at the Barcelona Institute of Global Health (ISGlobal), Hospital Clínic, University of Barcelona. His decade-long career as a health systems, HIV and hepatitis expert at WHO’s Regional Office for Europe was followed by three years at the Global Fund to Fight AIDS, Tuberculosis and Malaria, where he led knowledge translation.
Read more.

Tags:

Categorised in:

This post was written by easl_admin

Karlsen Tom

December 14, 2016 12:20 am Published by Leave your thoughts1 Comment% Comments

Tom Hemming Karlsen is a clinical specialist in internal medicine and gastroenterology working in Oslo, Norway. He is currently serving as Vice-Secretary of EASL. Within the Oslo University Hospital, he is head of research at the Division of Surgery, Inflammatory Medicine and Transplantation and leader of the Norwegian PSC research center at the Department of Transplantation Medicine and Research Institute of Internal Medicine. Clinically, he works as a senior consultant within transplant hepatology at the Section of Gastroenterology at the Department of Transplantation Medicine.
Read more.

Tags:

Categorised in:

This post was written by easl_admin